Probiotics in non-alcoholic fatty liver disease: which and when

Journal Title: Annals of Hepatology - Year 2013, Vol 12, Issue 3

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a common and serious disease. Literature reports the central role of the gut-liver axis in the pathogenesis of NAFLD, and recently suggests that the microbiota is a casual factor of the disease, involved in the interactions between intestinal lumen and liver. Probiotic are commensal bacteria, able to modulate the microbiota with benefits for the health of humans. Several data suggest a range of potentially beneficial medicinal uses for probiotics, in particular in NAFLD patients. However, the species with higher efficacy in this disease are not identified. The present review focuses on the role of gut-liver axis in the pathogenesis, and on the potential therapeutic role of probiotics in the managing of NAFLD

Authors and Affiliations

Ludovico Abenavoli, Emidio Scarpellini, Samir Rouabhia, Clara Balsano, Francesco Luzza

Keywords

Related Articles

Acute liver failure due to non-exertional heatstroke after sauna

Acute liver failure is defined as rapid loss of liver function that patients without previously recognized liver disease sustain a liver damage. Acute liver failure due to non-exertional heatstroke has rarely been report...

Hepatic venous pressure gradient measurement in pre-primary and primary prophylaxis of variceal hemorrhage

Pharmacological therapy of portal hypertensiĆ³n can be accomplished according to different objectives. Among them, pre-primary prophylaxis aims to avoid / delay esophageal varices development while the target of primary p...

Prevalence in vulnerable population of liver fibrosis identified by transient elastography

Background. Transient elastography (TE) is a useful tool for the assessment of hepatic fibrosis as an alternative to liver biopsy, but it has not been validated as a screening procedure in apparently healthy people. Aim....

Promotor methylation: Does it affect response to therapy in chronic Hepatitis C (G4) or fibrosis?

Background and aim. DNA methylation plays a critical role in the control of important cellular processes. The present study assessed the impact of promoter methylation (PM) of some genes on the antiviral response to anti...

Validation of the Simplified Criteria for the Diagnosis of Autoimmune Hepatitis in Chilean-Hispanic Patients

Introduction and aim. In 2008 the International autoimmune hepatitis (AIH) Group proposed the simplified diagnostic criteria for this disease. The original cohort study was performed in 11 international centers, but vali...

Download PDF file
  • EP ID EP78274
  • DOI -
  • Views 105
  • Downloads 0

How To Cite

Ludovico Abenavoli, Emidio Scarpellini, Samir Rouabhia, Clara Balsano, Francesco Luzza (2013). Probiotics in non-alcoholic fatty liver disease: which and when. Annals of Hepatology, 12(3), 357-363. https://europub.co.uk/articles/-A-78274